WELLESLEY HILLS, Mass. -- Point Therapeutics today announced that it has received proxies sufficient to approve the pending merger transaction with DARA BioSciences, Inc. and certain matters related ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results